Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-007489

Chief Reg & Develop Officer gave up 1,114 shares (to pay taxes)

  • Chief Reg & Develop Officer acquired 3,400 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Powala Christopher Chief Reg & Develop Officer 2019-02-01 Option exercise +3,400 142,843 D
Powala Christopher Chief Reg & Develop Officer 2019-02-01 Shares withheld for taxes −1,114 $6.96 $7,753 141,729 D
Derivatives
Powala Christopher Chief Reg & Develop Officer 2019-02-01 Option exercise · Restricted Stock Units −3,400 10,200 D
Loading xslF345X03/doc4.xml…